by Sue Robbins | Aug 18, 2019 | Migraine
Through the Global Burden of Diseases, Injuries, and Risk Factors (GBD) studies, headache has emerged as a major global public health concern. We aimed to use data from the GBD 2016 study to provide new estimates for prevalence and years of life lived with disability...
by Sue Robbins | Aug 18, 2019 | Migraine
Pfizer Inc. issued a voluntary nationwide recall Wednesday for two lots of Relpax (eletriptan hydrobromide) 40-milligram tablets due to the potential contamination. The lots are AR5407 and CD4565. Read more here.
by Sue Robbins | Aug 15, 2019 | Migraine
Migraine is underdiagnosed and undertreated, said Dawn C. Buse, PhD, clinical professor of neurology at Albert Einstein College of Medicine, New York, and colleagues. Read more here.
by Sue Robbins | Aug 13, 2019 | Migraine
A migraine plotline offers a teachable moment on an invisible disorder that disproportionately affects women. Read more here.
by Sue Robbins | Aug 12, 2019 | Migraine
An intravenous formulation of a calcitonin gene–related peptide inhibitor monoclonal antibody showed efficacy for preventing chronic migraine headaches for 3 months in a dose-ranging, phase 3 trial with 1,072 patients. Read more here.
